SCHEMBL11208452

SCHEMBL11208452

Cc1ccc(C(=O)Nc2ccc3cc(S(=O)(=O)O)cc(O)c3c2)c([N+](=O)[O-])c1.[NaH]

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NT5E P21589 2/20 0.54
▸ CASP6 P55212 2/20 0.46
▸ NSD2 O96028 2/20 0.46
▸ DUSP3 P51452 1/20 0.46
▸ PTPN5 P54829 1/20 0.46
▸ CASP7 P55210 1/20 0.46
▸ PTPN11 Q06124 1/20 0.46
▸ PRMT1 Q99873 1/20 0.46
▸ CTDSP1 Q9GZU7 1/20 0.44
▸ KCNMA1 Q12791 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ SNCA P37840 1/20 0.42
▸ MAPT P10636 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ ENPP2 Q13822 1/20 0.42
▸ TNF P01375 1/20 0.42
▸ NOD1 Q9Y239 1/20 0.42
▸ RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11428750 0.99 NT5E (0.55) NT5ECASP6NSD2DUSP3PTPN5
SCHEMBL11215156 0.92 NT5E (0.54) NT5ECASP6NSD2DUSP3PTPN5
SCHEMBL11436279 0.92 PRMT1 (0.56) NT5ECASP6NSD2DUSP3PTPN5
SCHEMBL11437160 0.92 KCNMA1 (0.45) NT5ECASP6NSD2DUSP3PTPN5
SCHEMBL11431542 0.91 NT5E (0.55) NT5ECASP6NSD2DUSP3PTPN5
SCHEMBL11424233 0.87 PRMT1 (0.48) CASP6NSD2DUSP3PTPN5PTPN11
SCHEMBL11426299 0.84 KCNMA1 (0.45) KCNMA1POLBMAPTMEN1KMT2A
SCHEMBL11432113 0.84 MAPT (0.43) KCNMA1POLBMAPTMEN1KMT2A
SCHEMBL11426442 0.84 KCNMA1 (0.45) NT5ECASP6KCNMA1POLBSNCA
SCHEMBL11433703 0.84 TNF (0.48) KCNMA1POLBMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0013784-B1 C-SUBSTITUTED NAPHTHALENEMONOSULFONIC UREIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AMERICAN CYANAMID COMPANY (US) 1983-02-23 — — EP disclosed
US-4297372-A ANTIARTHRITIC AGENTS; COLLAGENASE AND PROTEOLYTIC ENZYME INHIBITORS; BONE, SKIN, AND ORAL DISORDERS AMERICAN CYANAMID COMPANY (US) 1981-10-27 — — US disclosed
EP-0013784-A1 C-Substituted naphthalenemonosulfonic ureides, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1980-08-06 — — EP disclosed
US-4216165-A Amine precursors to ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 — — US disclosed
US-4216166-A Nitro precursors to amine precursors to ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 — — US disclosed
US-4216164-A Ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 — — US disclosed
Send feedback